Massivemarkets

SEC Form 4

Tandem Diabetes Care, Inc. (TNDM) insider trading

In the 12 months to Nov 17, 2026, 2 TNDM insiders reported open-market sales of $36.9K across 3 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$36.9K
3 filings · 2 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
2 of 3
$32.6K of $36.9K sold (88%)

Who traded TNDM, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

TNDM daily close from Nov 17, 2025 to Nov 16, 2026, between $12.82 and $28.26, last $18.48. 3 sale and 0 purchase filings by 2 insiders, marked at their filing dates. Christopher J. Twomey, Director: sold $32.6K across 1 filing, first filed Oct 29, 2026, last Oct 29, 2026. Mark David Novara, EVP & CHIEF COMMERCIAL OFFICER: sold $4.4K across 2 filings, first filed Mar 9, 2026, last Mar 18, 2026.

Largest mark · tap a row for others

Christopher J. Twomey · Director

Sale $32,555

1,700 shares at $19.15 avg

Filed Oct 29, 2026 · traded Oct 27

Pre-arranged (10b5-1) · close on filing date $19.79

TNDM daily closelast $18.48

Christopher J. Twomey · Director

$32.6K sold

Mark David Novara · EVP & CHIEF COMMERCIAL OFFICER

$4.4K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

3 filings in the last 12 months
Other insider activity (not market trades) · 162 records
  • Option exercises78 records
  • Tax withholding69 records
  • Grants and awards11 records
  • Gifts2 records
  • Other2 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Tandem Diabetes Care, Inc.'s CEO sold stock?

No. John F. Sheridan (CEO) made no open-market sales filed as CEO in the last 12 months.

How current is TNDM’s insider data?

These are TNDM Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track TNDM insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for TNDM every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.